UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
Want to see SG:8K7 full AI Analyst Report?
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.12
Previous CloseN/A
Volume145.10K
Average Volume (3M)131.00K
Market Cap
S$51.15M
Enterprise ValueS$74.60M
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained 51.77% revenue growth demonstrates durable demand and successful market penetration for its glove and protective-product lines. Strong top-line expansion provides scale to absorb fixed costs, supports capacity investment and distribution expansion, and underpins longer-term market-share gains.
Balance Sheet StrengthA high equity ratio (68.33%) and low debt-to-equity (0.30) indicate conservative financing and financial stability. This structural strength affords flexibility to fund working capital or capex, reduces refinancing risk during stress, and supports durable operational continuity over months.
Vertical Integration & DistributionOwning manufacturing, brands and distribution channels creates durable control over supply, quality and customer access. Vertical integration reduces reliance on third-party suppliers, helps manage margins and inventory across cycles, and supports stable relationships with institutional buyers over time.
Bears Say
ProfitabilityNegative net and EBIT margins show the company is not reliably converting sales into operating or bottom-line profits. Persistent margin pressure limits retained earnings, hampers reinvestment capacity, and signals structural cost or pricing issues that must be resolved to produce sustainable returns.
Deteriorating Cash GenerationA steep -78.07% decline in free cash flow growth and negative operating-cash-flow relative to net income indicate worsening cash conversion. Weaker cash generation constrains capex and working capital funding, increases dependence on external financing, and raises execution risk over the medium term.
Return On EquityA negative ROE signals the company is destroying shareholder capital rather than generating returns. Over a multi-month horizon this undermines investor confidence, limits ability to raise equity on favorable terms, and indicates the firm must change strategy or improve margins to deliver long-term value.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.07 and its highest was S$0.12 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$51.15M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 125 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 11, 2026. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UG Healthcare Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-2.36%
Trailing 12-Months
Asset Growth
-1.01%
Trailing 12-Months
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing essential products to hospitals, clinics, and healthcare providers worldwide. With a commitment to quality and innovation, UG Healthcare has established a strong reputation for its nitrile and latex gloves, catering to both the medical and industrial sectors.
Technical Analysis
Hyphens Pharma International Ltd.
―
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―